By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sierra Oncology (Formerly Known As ProNAi Therapeutics, Inc.) 

885 West Georgia Street
Suite 2150
Vancouver  British Columbia  V6C 3E8  Canada
Phone: 604-558-6536 Fax: n/a


Sierra Oncology is a clinical stage drug development company advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer. We are an ambitious company, oriented towards achieving the successful registration and commercialization of our drug candidates and we have a world-class management team with a proven track record of success in oncology drug development.


CEO: Nick Glover

CBO: Angie You

CMO: Mark Kowalski

CFO: Sukhi Jagpal


Please click here for Sierra Oncology job opportunities.


Please click here for clinical trial information.

Key Statistics

Ownership: Private

Web Site: Sierra Oncology

Company News
Sierra Oncology Establishes Distinguished DNA Damage Response Advisory Committee 8/15/2017 10:06:15 AM
Sierra Oncology Reports Second Quarter 2017 Results 8/10/2017 1:43:27 PM
Sierra Oncology Reports Encouraging Initial Progress From Ongoing Phase I Clinical Trials Of Chk1 Inhibitor SRA737 6/5/2017 6:54:58 AM
Sierra Oncology Granted US. And EU Patents For Chk1 inhibitor SRA737 5/30/2017 6:39:37 AM
Sierra Oncology Receives Clearance To Enhance Ongoing Clinical Trials For SRA737 5/10/2017 7:24:12 AM
Sierra Oncology Reports First Quarter 2017 Results 5/9/2017 11:10:43 AM
Sierra Oncology Collaborator ICR Reports Preclinical Synthetic Lethality Data For Chk1 Inhibitor SRA737 At AACR 4/3/2017 7:49:43 AM
Sierra Oncology Reports 2016 Year-End Results 3/2/2017 9:41:30 AM
With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside In Sierra Oncology 2/23/2017 6:07:51 AM
Sierra Oncology Announces Pricing Of Public Offering Of Common Stock 2/9/2017 10:07:17 AM